EUVIMEDOpdag EUVIMED
Open access

Potential roles of ROR-α in cardiovascular endocrinology

Saara Laitinen, Bart Staels

Nuclear Receptor Signaling · 2003

DOI: 10.1621/nrs.01011 ↗

At a glance

Journal article in Nuclear Receptor Signaling, 2003. Written by Saara Laitinen and 1 co-authors. Institution: UR545 INSERM, Institut Pasteur de Lille, and Faculte de Pharmacie, Universite de Lille II, 1 rue du Pr Calmette 59019 Lille, France. Cited 7 times so far (Crossref); 29 references. The full text is freely available in PubMed Central.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Atherosclerosis is a chronic disease of the arteries whose development involves a local inflammatory response characterized by the activation of different cells such as macrophages, T-lymphocytes, smooth muscle cells (SMCs) and endothelial cells (ECs). This review will summarize recent evidence for a modulatory role of the nuclear receptor ROR-alpha in cardiovascular disease.

Authors and institutions

  • UR545 INSERM, Institut Pasteur de Lille, and Faculte de Pharmacie, Universite de Lille II, 1 rue du Pr Calmette 59019 Lille, France.

Cite

APA

Laitinen, S., & Staels, B. (2003). Potential roles of ROR-α in cardiovascular endocrinology. Nuclear Receptor Signaling. https://doi.org/10.1621/nrs.01011

Vancouver

Laitinen S, Staels B. Potential roles of ROR-α in cardiovascular endocrinology. Nuclear Receptor Signaling. 2003. doi:10.1621/nrs.01011

BibTeX
@article{Laitinen2003,
  author = {Laitinen, Saara and Staels, Bart},
  title = {Potential roles of ROR-α in cardiovascular endocrinology},
  journal = {Nuclear Receptor Signaling},
  year = {2003},
  doi = {10.1621/nrs.01011}
}
Start for free →